Influenza Virus

CAS No.	Product Name	Inquiry
2478446-18-1	Zanamivir-Cholesterol Conjugate Zanamivir-cholesterol conjugate, a long-acting neuraminidase inhibitor, has potent efficacy against drug-resistant influenza viruses.
2485715-97-5	Cap-dependent-endonuclease-IN-7 Cap-dependent endonuclease-IN-7 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-7 Inhibits the synthesis of viral mRNA and eventually inhibits virus proliferation. Cap-dependent endonuclease-IN-7 has the potential for the research of viral infections (including influenza A, influenza B and influenza C).
2489248-15-7	Cap-dependent-endonuclease-IN-6 Cap-dependent endonuclease-IN-6 (compound 13) is a cap-dependent endonuclease (CEN) inhibitor. Cap-dependent endonuclease-IN-6 shows inhibition against influenza virus (EC50=38.21 nM).
24967-27-9	N-Acetyl-2,3-dehydro-2-deoxyneuraminic acid N-acetyl-2,3-dehydro-2-Deoxyneuraminic Acid is a potent neuraminidase (sialidase) inhibitor. It shows inhibitory activities against human neuraminidase enzymes with IC50s of 143, 43, 61, and 74 μM for NEU1, NEU2, NEU3, and NEU4, respectively.
251359-24-7	M2e-human M2e, human, consisting of the 23 extracellular residues of M2 (the third integral membrane protein of influenza A), has been remarkably conserved in all human influenza A, which is a valid and versatile vaccine candidate to protect against any strain of human influenza A.
254750-02-2	Emricasan Emricasan is a pan-caspase inhibitor with antiapoptotic and antiinflammatory activity. It was shown that emricasan decreased caspase activity, serum alanine aminotransferase (ALT), and hepatic fibrogenesis in a murine model of non-alcoholic steatohepatitis. Emricasan has been granted fast track designation by the FDA for the treatment of non-alcoholic steatohepatitis cirrhosis.
2567929-06-8	Cap-dependent-endonuclease-IN-19 Cap-dependent endonuclease-IN-19 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-19 is a spirocyclic pyridone derivative. Cap-dependent endonuclease-IN-19 has strong inhibitory effect on RNA polymerase activity of A virus.
2581298-44-2	Cap-dependent-endonuclease-IN-15 Cap-dependent endonuclease-IN-15 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-15 inhibits the replication of influenza virus. Cap-dependent endonuclease-IN-15 has the potential for the research of viral infections caused by Influenza Viruses.
2581825-57-0	Influenza-virus-IN-5 Influenza virus-IN-5 (Compound 5f) is an inhibitor of influenza virus hemagglutinin (HA) with an EC50 of 1 nM against influenza A/H3N2 virus.
2641942-32-5	Cap-dependent-endonuclease-IN-22 Cap-dependent endonuclease-IN-22 is a potent cap-dependent endonuclease (CEN) inhibitor.
2643370-92-5	Cap-dependent-endonuclease-IN-16 Cap-dependent endonuclease-IN-16 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-16 is a pyridone polycyclic derivative. Cap-dependent endonuclease-IN-16 has the potential for the research of influenza.
2649000-32-6	Cap-dependent-endonuclease-IN-24 Cap-dependent endonuclease-IN-24 is a potent cap-dependent endonuclease (CEN) inhibitor.
2649362-71-8	Cap-dependent-endonuclease-IN-17 Cap-dependent endonuclease-IN-17 is a cap-dependent endonuclease (CEN) inhibitor. Cap-dependent endonuclease-IN-17 shows antiviral activity against influenza virus A/Hanfang/359/95 (H3N2) with IC50 of 1.29 μM.
2649401-24-9	Cap-dependent-endonuclease-IN-18 Cap-dependent endonuclease-IN-18 is a potent cap-dependent endonuclease (CEN) inhibitor (CN112898312A, compound 14).
2656435-01-5	Cap-dependent-endonuclease-IN-20 Cap-dependent endonuclease-IN-20 is a cap-dependent endonuclease (CEN) inhibitor. Cap-dependent endonuclease-IN-20 shows antiviral activity against influenza virus A/Hanfang/359/95 (H3N2) with IC50 of 4.82 μM (CN112940009A; DSC801).
2658472-51-4	Cap-dependent-endonuclease-IN-11 Cap-dependent endonuclease-IN-11 is a potent inhibitor of cap-dependent endonuclease (CEN). Cap-dependent endonuclease-IN-11 has the potential for the research of viral infections.
2663989-04-4	Cap-dependent-endonuclease-IN-10 Cap-dependent endonuclease-IN-10 is a potent inhibitor of cap-dependent endonuclease (CEN). Not only can Cap-dependent endonuclease-IN-10 inhibit influenza virus well, but also has lower cytotoxicity, better in vivo pharmacokinetic and in vivo pharmacodynamic properties, and better hepatic microsomal stability. Cap-dependent endonuclease-IN-10 has the potential for the research of viral infections (including influenza A, influenza B and influenza C).
26833-85-2	HARRINGTONINE Harringtonine, isolated from Cephalotaxus harringtonia, inhibits protein synthesis at low micromolar concentrations and immobilizes ribosomes immediately after the initiation of translation.
2685786-28-9	Neuraminidase-IN-11 Neuraminidase-IN-11 (15e) is a potent and selective neuraminidase (NA) inhibitor with the IC50 values of 4.7 nM, 8.46 nM and 1.5 nM against H1N1, H5N1 and H5N8 NAs respectively.
2685786-29-0	Neuraminidase-IN-10 Neuraminidase-IN-10 is a potent neuraminidase (NA) inhibitor with anti-influenza activity. Neuraminidase-IN-10 is against H1N1, H5N1, and H5N8 with IC50 values of 2.6 nM, 5.1 nM, and 1.65 nM, respectively.

※ Please kindly note that our services are for research use only.